UBS Group’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.88M | Sell |
|
|||||
|
2025
Q2 | $2.42M | Sell |
|
|||||
|
2025
Q1 | $5.03M | Buy |
|
|||||
|
2024
Q4 | $3.37M | Buy |
|
|||||
|
2024
Q3 | $1.44M | Buy |
|
|||||
|
2024
Q2 | $942K | Sell |
|
|||||
|
2024
Q1 | $1.43M | Buy |
|
|||||
|
2023
Q4 | $1.12M | Sell |
|
|||||
|
2023
Q3 | $1.28M | Buy |
|
|||||
|
2023
Q2 | $162K | Sell |
|
|||||
|
2023
Q1 | $245K | Sell |
|
|||||
|
2022
Q4 | $477K | Sell |
|
|||||
|
2022
Q3 | $956K | Buy |
|
|||||
|
2022
Q2 | $728K | Sell |
|
|||||
|
2022
Q1 | $948K | Sell |
|
|||||
|
2021
Q4 | $2.78M | Buy |
|
|||||
|
2021
Q3 | $2.29M | Sell |
|
|||||
|
2021
Q2 | $2.81M | Buy |
|
|||||
|
2021
Q1 | $1.68M | Sell |
|
|||||
|
2020
Q4 | $2.19M | Sell |
|
|||||
|
2020
Q3 | $2M | Buy |
|
|||||
|
2020
Q2 | $226K | Sell |
|
|||||
|
2020
Q1 | $263K | Sell |
|
|||||
|
2019
Q4 | $3.4M | Buy |
|
|||||
|
2019
Q3 | $1.1M | Buy |
|
|||||
|
2019
Q2 | $307K | Sell |
|
|||||
|
2019
Q1 | $1.77M | Sell |
|
|||||
|
2018
Q4 | $1.46M | Sell |
|
|||||
|
2018
Q3 | $2.57M | Buy |
|
|||||
|
2018
Q2 | $1.12M | Buy |
|
|||||
|
2018
Q1 | $751K | Sell |
|
|||||
|
2017
Q4 | $2.18M | Sell |
|
|||||
|
2017
Q3 | $3.44M | Buy |
|
|||||
|
2017
Q2 | $3.19M | Buy |
|
|||||
|
2017
Q1 | $2.25M | Sell |
|
|||||
|
2016
Q4 | $2.51M | Buy |
|
|||||
|
2016
Q3 | $603K | Sell |
|
|||||
|
2016
Q2 | $749K | Buy |
|
|||||
|
2016
Q1 | $362K | Buy |
|
|||||
|
2015
Q4 | $309K | Sell |
|
|||||
|
2015
Q3 | $384K | Buy |
|
|||||
|
2015
Q2 | $345K | Buy |
|
|||||
|
2015
Q1 | $292K | Buy |
|
|||||
|
2014
Q4 | $173K | Buy |
|